GoalVest Advisory »

Jazz Pharmaceuticals shares owned by GoalVest Advisory

Quarter-by-quarter ownership of Jazz Pharmaceuticals (JAZZ) shares owned by GoalVest Advisory from 13F filings

Historical chart of GoalVest Advisory investment in Jazz Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Jazz Pharmaceuticals held by GoalVest Advisory consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Jazz Pharmaceuticals by GoalVest Advisory

Quarter filed Position value Share count Share price at filing
2025-12-31 $51k 300 170.00

More positions owned by GoalVest Advisory

Vanguard S&p 500 Etf Etf (VOO)
Vanguard Growth Etf Etf (VUG)
State Street Spdr Portfolio Intermediate Term Corporate Bond Etf Etf (SPIB)
Goldman Sachs Municipal Income Etf Etf (GMUB)
Ishares Core Msci Eafe Etf Etf (IEFA)
Vanguard Total Stock Market Etf Etf (VTI)
State Street Spdr Nyse Technology Etf Etf (XNTK)
Vanguard Ftse Europe Etf Etf (VGK)
Goldman Sachs Physical Gold Etf Etf (AAAU)
Palantir Technologies Inc Cl A Stock (PLTR)
Invesco Senior Loan Etf Etf (BKLN)
Nvidia Corporation Stock (NVDA)
Alphabet Inc Cap Stk Cl A Stock (GOOGL)
Tesla Stock (TSLA)
Microsoft Corp Stock (MSFT)

View all positions for GoalVest Advisory

Top funds holding Jazz Pharmaceuticals

Vanguard Group
BlackRock
Dimensional Fund Advisors
Capital World Investors
LSV Asset Management
State Street Corporation
Jpmorgan Chase & Co
Ameriprise Financial
EcoR1 Capital
Hanna Zanoni
Geode Capital Management
GoldenTree Asset Management
Swedbank AB
Citadel Advisors
Renaissance Technologies

View all funds holding Jazz Pharmaceuticals